Form 4: Aptevo Therapeutics Inc. Executive Exercises Stock Options and RSUs
SEC Form 4 Filing
SoYoung Kwon, SVP, GC, BD & Corp Affairs at Aptevo Therapeutics Inc., reports exercising stock options and Restricted Stock Units (RSUs) converting into common stock.
Summary
- SoYoung Kwon, a Senior Vice President at Aptevo Therapeutics Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report indicates the exercising of Restricted Stock Units (RSUs) that convert into common stock.
- On March 2, 2025, 2 RSUs were converted to common stock.
- On March 3, 2025, 2 RSUs were converted to common stock.
- The RSUs convert into common stock on a one-for-one basis.
- The reporting person directly owns the securities.
- The price of the derivative security was $0.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option exercises and RSU conversions, indicating standard compensation practices. It doesn't inherently suggest positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be an indicator of management's perspective on the company's stock.
Stakeholder Impact
- The exercise of RSUs may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| June 7, 2022 | Reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. |
| March 3, 2023 | Reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. |
| March 2, 2024 | First vesting date for RSUs granted on March 3, 2023. |
| March 2, 2025 | 2 RSUs converted to common stock. |
| March 3, 2025 | 2 RSUs converted to common stock. |
| March 4, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.